InvestorRoom | Kitov Pharmaceuticals TyrNovo Ltd. to Participate in 2017 BIO International Convention Company Selected by Israel Innovation Authority to Take Part in Israel Pavilion at World's Leading Biotech Conference Thu, 15 Jun 2017 10:58:00 -0400 Kitov Pharmaceuticals Files 6-K with Update on Israeli Securities Authority Investigation Mon, 01 May 2017 10:23:00 -0400 U.S. Food and Drug Administration Grants Kitov a Waiver for New Drug Application Filing Fee Mon, 03 Apr 2017 02:25:00 -0400 TyrNovo, a Kitov company, to Present Preclinical Data at the American Association for Cancer Research Annual Meeting Mon, 27 Mar 2017 08:58:00 -0400 Kitov Announces License Agreement for KIT-302 in South Korea Wed, 08 Mar 2017 09:03:00 -0500